DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chen KF, Tai WT, Liu TH. et al.
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
Clin Cancer Res 2010;
16 (21) 5189-5199
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.